Strongyloides in bronchoalveolar lavage fluid: practical implications in the COVID-19 era

J Travel Med. 2022 Jan 17;29(1):taab114. doi: 10.1093/jtm/taab114.

Abstract

Latent infections caused by Strongyloides sp. may become symptomatic years after initial exposure in endemic areas especially in specific contexts such as following administration of corticosteroids (for COVID-19 or other diseases). Heightened awareness of these reactivations and timely diagnosis may be critical to prevent complications and improve outcome.

Keywords: Strongyloides; COVID-19; immunosuppression; steroids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchoalveolar Lavage
  • Bronchoalveolar Lavage Fluid
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Strongyloides stercoralis*
  • Strongyloidiasis* / diagnosis